The study suggests that the CAC score may aid in better risk stratification in patients with heterozygous familial hypercholesterolemia.
Does coronary calcium score improve risk stratification in patients with heterozygous familial hypercholesterolemia?
Coronary calcium scoring and SAFEHEART-RE may be useful tools for better risk stratification in patients with heterozygous familial hypercholesterolemia.
Absolute Event Rate: 0% vs 0%
Early diagnosis and early initiation of appropriate treatment are essential for reducing the accumulated cholesterol burden in patients with HeFH. Given the heterogeneity in CVD in patients with HeFH, tools such as the SAFEHEART-RE and CAC score may be useful for better risk stratification.
Lorea et al. (Tue,) reported a other. The study suggests that the CAC score may aid in better risk stratification in patients with heterozygous familial hypercholesterolemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: